iRhythm Technologies 주식 (NASDAQ: IRTC)

에 대한 최신 뉴스 iRhythm Technologies (NASDAQ:IRTC) 주식

iRhythm Technologies

iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities. The company's portfolio includes ambulatory cardiac monitoring services on a platform, called the Zio service, which combines an easy-to-wear and unobtrusive biosensor that can be worn for several days with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company derived its revenue from the United States.

News

Movers

AMKR

BILI

BRFS

IBRX

IRTC

ITCI

OLLI

RKLB

TALO

이들 중형주들은 지난주 최고의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요? 빌리빌리(NASDAQ:BILI)의 주가는 지난주 &#39;산구오: 무딩티엔샤(San Guo: Mou Ding Tian Xia)&#39; 발표 이후 23.32% 상승했다. 또한 JP모건 애널리스트 다니엘 첸(Daniel Chen)은 중국의 빌리빌리를 중립에서 비중확대로 상향 조정하고 21달러 가격 목표를 발표했다. 

빌리빌리와 올리즈 바겐은 지난주 최대 성과를 보인 10개 중형주 중 일부 (6월 16일-6월 22일)

iRhythm Technologies, Inc. - Common Stock

iRhythm Technologies Inc

<p>Financial giants have made a conspicuous bullish move on Li Auto. Our analysis of options history for Li Auto (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LI#NASDAQ">LI</a>) revealed 13 unusual trades.</p>
<p>Delving into the details, we found 76% of traders were bullish, while 23% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $123,832, and 10 were calls, valued at $507,255.</p>
<h3>Predicted Price Range</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $17.0 and $40.0 for Li Auto, spanning the last three months.</p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<p>This data can help you track the liquidity and interest for Li Auto's options for a given strike price.</p>
<p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Li Auto's whale activity within a strike price range from $17.0 to $40.0 in the last 30 days. </p>
<h3>Li Auto 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1720730867_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>LI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/18/24</td>
<td>$2.64</td>
<td>$2.63</td>
<td>$2.63</td>
<td>$22.00</td>
<td>$99.2K</td>
<td>982</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>LI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/18/24</td>
<td>$1.42</td>
<td>$1.33</td>
<td>$1.4</td>
<td>$26.00</td>
<td>$72.9K</td>
<td>180</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>LI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/15/24</td>
<td>$3.35</td>
<td>$3.3</td>
<td>$3.3</td>
<td>$21.00</td>
<td>$66.0K</td>
<td>4.2K</td>
<td style="text-align: right;">4</td>
</tr>
<tr>
<td>LI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/20/24</td>
<td>$2.68</td>
<td>$2.65</td>
<td>$2.68</td>
<td>$21.00</td>
<td>$53.6K</td>
<td>835</td>
<td style="text-align: right;">22</td>
</tr>
<tr>
<td>LI</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$1.41</td>
<td>$1.35</td>
<td>$1.35</td>
<td>$17.00</td>
<td>$49.4K</td>
<td>933</td>
<td style="text-align: right;">68</td>
</tr>
</tbody>
</table>
</p>
<h3>About Li Auto</h3>
<p>Li Auto is a leading Chinese NEV manufacturer that designs, develops, manufactures, and sells premium smart NEVs. The company started volume production of its first model Li One in November 2019. The model is a six-seater, large, premium plug-in electric SUV equipped with a range extension system and advanced smart vehicle solutions. It sold over 376,000 NEVs in 2023, accounting for about 4% of China's passenger new energy vehicle market. Beyond Li One, the company expands its product line, including both BEVs and PHEVs, to target a broader consumer base.</p>
<h3>Current Position of Li Auto</h3>
<ul>
<li>Currently trading with a volume of 8,588,074, the LI's price is up by 3.42%, now at $21.44. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 26 days.</li>
</ul>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Li Auto with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


Options

Markets

Li Auto's Options: A Look at What the Big Money is Thinking

<p>Investors with a lot of money to spend have taken a bullish stance on <strong>Starbucks</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with SBUX, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 32 uncommon options trades for Starbucks.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 62% bullish and 37%, bearish.</p>
<p>Out of all of the special options we uncovered, 17 are puts, for a total amount of $1,919,523, and 15 are calls, for a total amount of $1,480,641.</p>
<h3>Projected Price Targets</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $40.0 to $100.0 for Starbucks over the recent three months. </p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Starbucks's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Starbucks's whale trades within a strike price range from $40.0 to $100.0 in the last 30 days. </p>
<h3>Starbucks Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1720730862_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>SBUX</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/20/24</td>
<td>$2.75</td>
<td>$2.71</td>
<td>$2.71</td>
<td>$70.00</td>
<td>$813.0K</td>
<td>13.2K</td>
<td style="text-align: right;">187</td>
</tr>
<tr>
<td>SBUX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/20/24</td>
<td>$3.45</td>
<td>$3.4</td>
<td>$3.45</td>
<td>$75.00</td>
<td>$690.0K</td>
<td>3.6K</td>
<td style="text-align: right;">393</td>
</tr>
<tr>
<td>SBUX</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/18/26</td>
<td>$8.5</td>
<td>$5.6</td>
<td>$5.9</td>
<td>$60.00</td>
<td>$236.0K</td>
<td>1.1K</td>
<td style="text-align: right;">2</td>
</tr>
<tr>
<td>SBUX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$7.9</td>
<td>$7.75</td>
<td>$7.75</td>
<td>$75.00</td>
<td>$139.5K</td>
<td>2.0K</td>
<td style="text-align: right;">7</td>
</tr>
<tr>
<td>SBUX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/18/26</td>
<td>$22.5</td>
<td>$21.3</td>
<td>$21.3</td>
<td>$60.00</td>
<td>$134.1K</td>
<td>29</td>
<td style="text-align: right;">1</td>
</tr>
</tbody>
</table>
</p>
<h3>About Starbucks</h3>
<p>Starbucks is one of the most widely recognized restaurant brands in the world, operating more than 38,000 stores across more than 80 countries as of the end of fiscal 2023. The firm operates in three segments: North America, international markets, and channel development (grocery and ready-to-drink beverage). The coffee chain generates revenue from company-operated stores, royalties, sales of equipment and products to license partners, ready-to-drink beverages, packaged coffee sales, and single-serve products.</p>
<p>Having examined the options trading patterns of Starbucks, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Starbucks's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 12,285,192, the SBUX's price is up by 1.09%, now at $73.3. </li>
<li>RSI readings suggest the stock is currently may be oversold.</li>
<li>Anticipated earnings release is in 19 days.</li>
</ul>
<h3>Professional Analyst Ratings for Starbucks</h3>
<p>A total of 3 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $85.33333333333333.</p>
<ul>
<li>An analyst from Wedbush downgraded its action to Neutral with a price target of $81. </li>
<li>An analyst from JP Morgan persists with their Overweight rating on Starbucks, maintaining a target price of $90. </li>
<li>Reflecting concerns, an analyst from TD Cowen lowers its rating to Hold with a new price target of $85.</li>
</ul>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Starbucks with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


SBUX

What the Options Market Tells Us About Starbucks

<p>Deep-pocketed investors have adopted a bullish approach towards C3.ai (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AI#NYSE">AI</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in AI usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 8 extraordinary options activities for C3.ai. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 62% leaning bullish and 37% bearish. Among these notable options, 3 are puts, totaling $167,716, and 5 are calls, amounting to $246,100.</p>
<h3>What's The Price Target?</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $30.0 to $50.0 for C3.ai over the recent three months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in C3.ai's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to C3.ai's substantial trades, within a strike price spectrum from $30.0 to $50.0 over the preceding 30 days.</p>
<h3>C3.ai Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1720730857_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>AI</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/16/24</td>
<td>$1.35</td>
<td>$1.33</td>
<td>$1.34</td>
<td>$30.00</td>
<td>$106.2K</td>
<td>6.7K</td>
<td style="text-align: right;">58</td>
</tr>
<tr>
<td>AI</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$4.7</td>
<td>$4.4</td>
<td>$4.6</td>
<td>$32.50</td>
<td>$91.9K</td>
<td>1.9K</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>AI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$2.91</td>
<td>$2.9</td>
<td>$2.9</td>
<td>$37.50</td>
<td>$58.0K</td>
<td>954</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>AI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/19/24</td>
<td>$0.98</td>
<td>$0.78</td>
<td>$0.89</td>
<td>$31.00</td>
<td>$43.0K</td>
<td>1.2K</td>
<td style="text-align: right;">33</td>
</tr>
<tr>
<td>AI</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$21.95</td>
<td>$21.55</td>
<td>$21.95</td>
<td>$50.00</td>
<td>$30.7K</td>
<td>14</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
</p>
<h3>About C3.ai</h3>
<p>C3.ai Inc is an enterprise artificial intelligence company. The company provides software-as-a-service applications that enable customers to rapidly develop, deploy, and operate large-scale Enterprise AI applications across any infrastructure. It provides solutions under three divisions namely, The C3 AI Platform, which is an end-to-end application development and runtime environment for designing, developing, and deploy AI applications: C3 AI Applications, which is a portfolio of pre-built, extensible, industry-specific, and application-specific Enterprise AI applications: and C3 Generative AI, which combines the utility of large language models. Geographically the company derives revenue from North America, Europe, the Middle East and Africa, Asia Pacific, and the Rest of World.</p>
<h3>Where Is C3.ai Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 4,209,344, the AI's price is down by -0.53%, now at $29.8. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 55 days.</li>
</ul>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for C3.ai, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Spotlight on C3.ai: Analyzing the Surge in Options Activity

<p>Jones Trading  analyst Justin Walsh   initiates coverage on Y-mAbs Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YMAB#NASDAQ">YMAB</a>) with a Buy rating and announces Price Target of $23.</p>


Price Target

Initiation

Analyst Ratings

YMAB

Jones Trading Initiates Coverage On Y-mAbs Therapeutics with Buy Rating, Announces Price Target of $23

Offerings

SISI

Shineco Commences Public Offering Of Shares Of Its Common Stock And Pre-funded Warrants To Purchase Common Stock

CPSS

Consumer Portfolio Services Renews Two-year Revolving Credit Agreement With Citibank

<p>The refinancing provides improved liquidity, lower cash costs, and greater financial flexibility for the Company.&nbsp;</p>
<p>The revolving line of credit was expanded from&nbsp;$115 million&nbsp;to a&nbsp;$200 million&nbsp;maximum subject to the borrowing base, with an interest rate of SOFR plus&nbsp;2.5%&nbsp;to&nbsp;3.0%&nbsp;varying based on the Company&#39;s consolidated leverage ratio.&nbsp;</p>


ATRO

Astronics Amends, Expands Revolving Line Of Credit And Refinanced Its Term Loan

<p>Compass Point  analyst Casey Alexander   upgrades Saratoga Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAR#NYSE">SAR</a>) from Neutral to Buy and maintains the price target from $24.75 to $24.75.</p>


Upgrades

Compass Point Upgrades Saratoga Investment to Buy, Maintains Price Target to $24.75

<p><strong><em>By <a href="https://elplanteo.com/author/lucia-tedesco/" target="_blank" rel="noreferrer noopener">Lucía Tedesco</a> via <a href="https://elplanteo.com/marihuana-argentina-exporta-europa/" target="_blank" rel="noreferrer noopener">El Planteo</a></em></strong></p>
<p>Citing violations of municipal ordinances, the <strong>Barcelona City Council,</strong> led by <strong>Jaume Collboni,</strong> has ordered the closure of 30 cannabis clubs. However, it seems that all such clubs in the city might eventually be shut down.</p>
<p>In 2023, Barcelona had 200 clubs, serving as the primary access point for cannabis users. At that time, Deputy Mayor and Security Councilor <strong>Albert Batlle</strong> announced the City Council&#8217;s intention to close all of them, as reported by ABC. By the end of that year, a series of inspections began, where municipal agents stopped club members as they left, questioning them about their activities, whether they bought cannabis and if non-residents visited the clubs.</p>
<h3 class="wp-block-heading">Urban Guard Data Compromises Barcelona&#8217;s Cannabis Clubs</h3>
<p>Following these inspections, sources from the urban guard said that there was a significant influx of non-resident tourists entering the clubs.</p>
<p>Following the closure order, the clubs have ten days to present a case, allowing the judiciary to determine whether the shutdown will be temporary or permanent. In the event of a potential reopening, it is stated that there will be &#8220;strict surveillance.&#8221;</p>
<p>Currently, the clubs lack a legal framework to protect them. In fact, in 2021, the Supreme Court upheld a ruling against a regulation approved by the City Council, brought forward by representative <strong>Ada Colau</strong> in 2016, which governed these establishments.</p>
<p>Since then, the regulation of the clubs has been precarious, a consequence of a failure to implement the appropriate policies in due time.</p>
<p><em>This article is from an external unpaid contributor. It does not represent Benzinga&#8217;s reporting and has not been edited for content or accuracy.</em></p>
<p>Photo by <a href="https://unsplash.com/@loganstrongarms?utm_content=creditCopyText&amp;utm_medium=referral&amp;utm_source=unsplash">Logan Armstrong</a> on <a href="https://unsplash.com/photos/aerial-view-of-city-buildings-during-daytime-hVhfqhDYciU?utm_content=creditCopyText&amp;utm_medium=referral&amp;utm_source=unsplash">Unsplash</a></p>


Cannabis

Barcelona Vs Weed: City Council Orders Shutdown Of 30 Cannabis Clubs

<p>The larger-than-expected drop in the June Consumer Price Index inflation rate has fueled market expectations for interest rate cuts <a href="https://www.benzinga.com/topic/interest-rates">by the Federal Reserve.</a></p>
<p>Investors no longer seem to have doubts and are assigning a 91% implied probability that rate cuts will begin as early as September 2024.</p>
<p>The upcoming Producer Price Index (PPI) inflation report, scheduled for release on Friday at 8:30 a.m. ET, will be crucial in determining whether producer price trends can continue to support rate-cut expectations or temper the optimism.</p>
<h3 class="wp-block-heading">June PPI Preview: What Economists Expect</h3>
<ul>
<li>Producer prices in June are expected to rise 0.1% on the month versus an unexpected 0.2% decline in May, according to economist consensus estimates, as tracked by TradingEconomics. </li>
<li>On an annual basis, the PPI inflation is expected to accelerate from 2.2% to 2.3%.</li>
<li>Excluding food and energy, core PPI is expected to advance by 0.2% month-over-month, accelerating from the previous flat reading. </li>
<li>Annually, core producer prices are set to rise by 2.5%, up from 2.3% in May. That would mark the highest annual core producer inflation rate since August 2023. </li>
</ul>
<h3 class="wp-block-heading">5 ETFs To Watch Friday</h3>
<p>On Thursday, traders favored markets poised to gain <a href="https://www.benzinga.com/markets/asia/24/07/39733667/inflation-data-sparks-rush-for-gold-real-estate-treasuries-yen-traders-see-september-rate-cut-as-don">from future rate cuts,</a> investing in sectors that could benefit from reduced borrowing costs, while penalizing assets that had already heavily discounted expectations of monetary policy shifts.</p>
<p>The producer inflation data will be pivotal in evaluating if this market momentum will persist. </p>
<p>Among Thursday&#8217;s top-performing exchange-traded funds, we can definitely mention:</p>
<ul>
<li><strong>SPDR Homebuilders ETF</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XHB#NYSE">XHB</a>) rallying 6.1%</li>
<li><strong>Invesco Solar ETF</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAN#NYSE">TAN</a>) rising 4.4%</li>
<li><strong>SPDR S&amp;P Regional Banking ETF</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KRE#NYSE">KRE</a>) up 4.2%</li>
<li><strong>iShares Russell 2000 ETF</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) up 3.6%</li>
<li><strong>VanEck Gold Miners ETF</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GDX#NYSE">GDX</a>) up 2.9%</li>
</ul>
<p>Read now: </p>
<ul>
<li><strong><a href="https://www.benzinga.com/general/politics/24/07/39731800/biden-cheers-inflation-progress-rate-cut-chorus-grows-louder-among-5-economists-this-is-just-wha">Biden Cheers Inflation Progress, Rate Cut Chorus Grows Louder Among 5 Economists: &#8216;This Is Just What The JayMan Needed&#8217;</a></strong></li>
</ul>
<p><em>Image created using artificial intelligence via Midjourney.</em></p>


Equities

Large Cap

Macro Economic Events

Sector ETFs

Econ #s

Economics

Federal Reserve

ETFs

Market Vectors ETF Trust Market Vectors Gold Miners

Could June Producer Inflation Data Dampen Market Enthusiasm For Rate-Cut Winners? 5 ETFs To Watch Friday

<p>Financial giants have made a conspicuous bearish move on Cytokinetics. Our analysis of options history for Cytokinetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYTK#NASDAQ">CYTK</a>) revealed 18 unusual trades.</p>
<p>Delving into the details, we found 16% of traders were bullish, while 66% showed bearish tendencies. Out of all the trades we spotted, 2 were puts, with a value of $63,000, and 16 were calls, valued at $1,379,080.</p>
<h3>Expected Price Movements</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $35.0 to $75.0 for Cytokinetics over the recent three months. </p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<p>This data can help you track the liquidity and interest for Cytokinetics's options for a given strike price.</p>
<p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Cytokinetics's whale activity within a strike price range from $35.0 to $75.0 in the last 30 days. </p>
<h3>Cytokinetics 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1720729912_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th style="text-align: right;"><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>CYTK</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$24.2</td>
<td>$24.0</td>
<td>$24.0</td>
<td>$35.00</td>
<td>$120.0K</td>
<td style="text-align: right;">801</td>
<td style="text-align: right;">50</td>
</tr>
<tr>
<td>CYTK</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$24.2</td>
<td>$24.0</td>
<td>$24.0</td>
<td>$35.00</td>
<td>$120.0K</td>
<td style="text-align: right;">801</td>
<td style="text-align: right;">550</td>
</tr>
<tr>
<td>CYTK</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$24.2</td>
<td>$24.0</td>
<td>$24.0</td>
<td>$35.00</td>
<td>$120.0K</td>
<td style="text-align: right;">801</td>
<td style="text-align: right;">550</td>
</tr>
<tr>
<td>CYTK</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$24.2</td>
<td>$24.0</td>
<td>$24.0</td>
<td>$35.00</td>
<td>$120.0K</td>
<td style="text-align: right;">801</td>
<td style="text-align: right;">300</td>
</tr>
<tr>
<td>CYTK</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$24.2</td>
<td>$24.0</td>
<td>$24.0</td>
<td>$35.00</td>
<td>$120.0K</td>
<td style="text-align: right;">801</td>
<td style="text-align: right;">300</td>
</tr>
</tbody>
</table>
</p>
<h3>About Cytokinetics</h3>
<p>Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.</p>
<p>Having examined the options trading patterns of Cytokinetics, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Present Market Standing of Cytokinetics</h3>
<ul>
<li>With a volume of 1,441,074, the price of CYTK is up 2.49% at $56.3. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 21 days.</li>
</ul>
<h3>Professional Analyst Ratings for Cytokinetics</h3>
<p>In the last month, 2 experts released ratings on this stock with an average target price of $77.5.</p>
<ul>
<li>Maintaining their stance, an analyst from JP Morgan continues to hold a Overweight rating for Cytokinetics, targeting a price of $65. </li>
<li>In a cautious move, an analyst from HC Wainwright &amp; Co. downgraded its rating to Buy, setting a price target of $90. </li>
</ul>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Cytokinetics, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


CYTK

A Closer Look at Cytokinetics's Options Market Dynamics

<p>Deep-pocketed investors have adopted a bullish approach towards D.R. Horton (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHI#NYSE">DHI</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in DHI usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 30 extraordinary options activities for D.R. Horton. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 43% leaning bullish and 33% bearish. Among these notable options, 8 are puts, totaling $284,454, and 22 are calls, amounting to $1,811,598.</p>
<h3>Predicted Price Range</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $110.0 to $165.0 for D.R. Horton during the past quarter. </p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for D.R. Horton's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of D.R. Horton's whale trades within a strike price range from $110.0 to $165.0 in the last 30 days. </p>
<h3>D.R. Horton Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1720729908_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>DHI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/19/24</td>
<td>$10.2</td>
<td>$9.1</td>
<td>$9.8</td>
<td>$140.00</td>
<td>$784.0K</td>
<td>1.7K</td>
<td style="text-align: right;">161</td>
</tr>
<tr>
<td>DHI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$8.0</td>
<td>$7.6</td>
<td>$7.87</td>
<td>$160.00</td>
<td>$103.5K</td>
<td>506</td>
<td style="text-align: right;">2</td>
</tr>
<tr>
<td>DHI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>11/15/24</td>
<td>$8.9</td>
<td>$8.6</td>
<td>$8.7</td>
<td>$155.00</td>
<td>$93.3K</td>
<td>195</td>
<td style="text-align: right;">19</td>
</tr>
<tr>
<td>DHI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$12.5</td>
<td>$11.5</td>
<td>$12.49</td>
<td>$145.00</td>
<td>$90.3K</td>
<td>94</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>DHI</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>07/26/24</td>
<td>$6.7</td>
<td>$6.4</td>
<td>$6.5</td>
<td>$147.00</td>
<td>$65.0K</td>
<td>0</td>
<td style="text-align: right;">100</td>
</tr>
</tbody>
</table>
</p>
<h3>About D.R. Horton</h3>
<p>D.R. Horton is a leading homebuilder in the United States with operations in 118 markets across 33 states. D.R. Horton mainly builds single-family detached homes (over 90% of home sales revenue) and offers products to entry-level, move-up, luxury buyers, and active adults. The company offers homebuyers mortgage financing and title agency services through its financial services segment. D.R. Horton's headquarters are in Arlington, Texas, and it manages six regional segments across the United States.</p>
<h3>D.R. Horton's Current Market Status</h3>
<ul>
<li>Trading volume stands at 4,529,163, with DHI's price up by 7.26%, positioned at $149.73.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 7 days.</li>
</ul>
<h3>Expert Opinions on D.R. Horton</h3>
<p>A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $156.0.</p>
<ul>
<li>An analyst from Citigroup has revised its rating downward to Neutral, adjusting the price target to $156. </li>
</ul>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for D.R. Horton, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


D.R. Horton's Options: A Look at What the Big Money is Thinking

<p><strong>George R.R. Martin </strong>has revealed a striking set of new covers for his epic fantasy series, A Song of Ice and Fire. </p>
<p>The announcement, made via Martin&#8217;s <a href="https://georgerrmartin.com/notablog/2024/07/10/a-bold-new-look-for-the-a-song-of-ice-and-fire-boxed-set/">blog,</a> &#8220;Not a Blog,&#8221; showcases a collection of artwork that promises to redefine the visual identity of this beloved saga.</p>
<p><strong>See Also: <a href="https://www.benzinga.com/general/entertainment/24/07/39579853/george-r-r-martin-fuels-rumors-about-elden-ring-movie-or-tv-show">George R. R. Martin Fuels Rumors About Elden Ring Movie Or TV Show</a></strong></p>
<p>The new covers, set to grace both individual volumes and a boxed set of the entire series, feature artwork crafted using traditional linocut and woodcut techniques.</p>
<p>According to the post, the designs were brought to life through the collaborative efforts of linocut artist <strong>Mark Seekins</strong>, designer <strong>Tim Green</strong>, and art director <strong>David G. Stevenson</strong>. </p>
<p>The process involved meticulous sketching, carving intricate designs into linoleum blocks, and layering multiple colors to achieve a rich, textured effect.</p>
<p>&#8220;There is a raw and gritty quality to linocut and woodcut art,&#8221; Martin&#8217;s blog post explained, &#8220;A certain starkness that seemed to fit the stories, and a long history to the art form that felt right for this world.&#8221;</p>
<h3 class="wp-block-heading"><strong>Introducing New &#8216;Song of Ice And Fire&#8217; Covers</strong></h3>
<p>The unveiling of these covers marks a significant moment for fans, who can expect to find the boxed set available online and in stores starting October 2024. However, specific pricing details have yet to be disclosed.</p>
<p>Meanwhile, despite the excitement surrounding this visual refresh, Martin&#8217;s announcement inevitably raises questions about the progress of the series&#8217; eagerly anticipated next installment, The Winds of Winter. </p>
<p>Originally slated for completion years ago, the novel remains a work in progress, with Martin acknowledging the challenges of bringing the intricate narrative to a satisfying conclusion.</p>
<p>&#8220;No writer is blessed with producing a perfect first draft,&#8221; Martin commented in his blog, addressing the ongoing saga of The Winds of Winter&#8217;s development. Despite having reportedly written 1,100 pages of the novel as of November 2023, he admits the meticulous process of revision and refinement continues.</p>
<h3 class="wp-block-heading"><strong>Here Are Some Of R. R. Martin&#8217;s New Covers: </strong></h3>
<p><figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="678" height="1024" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/11150225/agameofthrones_2024_tr_repackage-768x1160-1-678x1024.jpeg" alt="" class="wp-image-431887" style="width:365px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/11150225/agameofthrones_2024_tr_repackage-768x1160-1-678x1024.jpeg 678w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/11150225/agameofthrones_2024_tr_repackage-768x1160-1-199x300.jpeg 199w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/11150225/agameofthrones_2024_tr_repackage-768x1160-1.jpeg 715w" sizes="(max-width: 678px) 100vw, 678px" /><figcaption class="wp-element-caption">Image Credit: George R.R. Martin &#8211; Not a Blog</figcaption></figure></p>
<p><figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="678" height="1024" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/11150836/aclashofkings_2024_tr_repackage-768x1160-1-678x1024.jpeg" alt="" class="wp-image-431902" style="width:358px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/11150836/aclashofkings_2024_tr_repackage-768x1160-1-678x1024.jpeg 678w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/11150836/aclashofkings_2024_tr_repackage-768x1160-1-199x300.jpeg 199w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/11150836/aclashofkings_2024_tr_repackage-768x1160-1.jpeg 715w" sizes="(max-width: 678px) 100vw, 678px" /><figcaption class="wp-element-caption">Image Credit: George R.R. Martin &#8211; Not a Blog</figcaption></figure></p>
<p><figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="678" height="1024" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/11150951/astormofswords_2024_tr_repackage-768x1160-1-678x1024.jpeg" alt="" class="wp-image-431904" style="width:359px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/11150951/astormofswords_2024_tr_repackage-768x1160-1-678x1024.jpeg 678w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/11150951/astormofswords_2024_tr_repackage-768x1160-1-199x300.jpeg 199w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/11150951/astormofswords_2024_tr_repackage-768x1160-1.jpeg 715w" sizes="(max-width: 678px) 100vw, 678px" /><figcaption class="wp-element-caption">Image Credit: George R.R. Martin &#8211; Not a Blog</figcaption></figure></p>
<p><strong>Read Next: </strong></p>
<ul>
<li><a href="https://www.benzinga.com/general/entertainment/24/01/36598447/game-of-thrones-creators-spill-secrets-on-axed-star-wars-project-we-werent-the-droids-they-"><strong>&#8216;Game Of Thrones&#8217; Creators Spill Secrets On Axed &#8216;Star Wars&#8217; Project: &#8216;We Weren&#8217;t The Droids They Were Looking For&#8217;</strong></a></li>
</ul>
<p><em>Image credits: Shutterstock.</em></p>


Entertainment

General

Check Out George R.R. Martin's Stunning New 'Game Of Thrones' Covers: 'Raw And Gritty Quality — Right For This World'

<p>Mastercard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MA#NYSE">MA</a>) has outperformed the market over the past 15 years by 11.11% on an annualized basis producing an average annual return of 23.69%. Currently, Mastercard has a market capitalization of $408.30 billion. </p>
<p><strong>Buying $1000 In MA:</strong> If an investor had bought $1000 of MA stock 15 years ago, it would be worth <strong>$24,480.84</strong> today based on a price of $439.22 for MA at the time of writing.</p>
<h3>Mastercard's Performance Over Last 15 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1720729904_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Trading Ideas

If You Invested $1000 In This Stock 15 Years Ago, You Would Have $24,000 Today

<p>High-rolling investors have positioned themselves bearish on PENN Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PENN#NASDAQ">PENN</a>), and it's important for retail traders to take note.<br />
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in PENN often signals that someone has privileged information.</p>
<p>Today, Benzinga's options scanner spotted 14 options trades for PENN Entertainment. This is not a typical pattern.</p>
<p>The sentiment among these major traders is split, with 35% bullish and 57% bearish. Among all the options we identified, there was one put, amounting to $40,086, and 13 calls, totaling $672,415.</p>
<h3>Projected Price Targets</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $15.0 to $25.0 for PENN Entertainment over the recent three months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in PENN Entertainment's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to PENN Entertainment's substantial trades, within a strike price spectrum from $15.0 to $25.0 over the preceding 30 days.</p>
<h3>PENN Entertainment Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1720729902_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>PENN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$7.3</td>
<td>$6.95</td>
<td>$6.95</td>
<td>$15.00</td>
<td>$161.9K</td>
<td>1.1K</td>
<td style="text-align: right;">567</td>
</tr>
<tr>
<td>PENN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$7.0</td>
<td>$6.9</td>
<td>$6.9</td>
<td>$15.00</td>
<td>$104.2K</td>
<td>1.1K</td>
<td style="text-align: right;">335</td>
</tr>
<tr>
<td>PENN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$6.8</td>
<td>$6.75</td>
<td>$6.8</td>
<td>$15.00</td>
<td>$70.7K</td>
<td>1.1K</td>
<td style="text-align: right;">160</td>
</tr>
<tr>
<td>PENN</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$2.95</td>
<td>$2.89</td>
<td>$2.9</td>
<td>$20.00</td>
<td>$43.5K</td>
<td>19.0K</td>
<td style="text-align: right;">27</td>
</tr>
<tr>
<td>PENN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$1.98</td>
<td>$1.96</td>
<td>$1.97</td>
<td>$20.00</td>
<td>$40.0K</td>
<td>1.0K</td>
<td style="text-align: right;">91</td>
</tr>
</tbody>
</table>
</p>
<h3>About PENN Entertainment</h3>
<p>Penn Entertainment's origins date back to its 1972 racetrack opening in Pennsylvania. Today, Penn operates 43 properties across 20 states and 12 brands, including Hollywood Casino and Ameristar. Land-based casinos represented 89% of total sales in 2023; 11% was from the interactive segment, which includes sports, iGaming, and media revenue. The retail portfolio generates mid-30s EBITDAR margins and helps position the company to obtain licenses for the digital wagering markets. Additionally, Penn's media assets, theScore and ESPN (starting with its partnership launch in November 2023), provide access to sports betting/iGaming technology and clientele, helping it form a leading digital position.</p>
<p>In light of the recent options history for PENN Entertainment, it's now appropriate to focus on the company itself. We aim to explore its current performance.</p>
<h3>Present Market Standing of PENN Entertainment</h3>
<ul>
<li>Currently trading with a volume of 8,170,710, the PENN's price is up by 3.49%, now at $20.77. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 28 days.</li>
</ul>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest PENN Entertainment options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


PENN

Market Whales and Their Recent Bets on PENN Options

<p>Alphabet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) has outperformed the market over the past 10 years by 9.29% on an annualized basis producing an average annual return of 20.18%. Currently, Alphabet has a market capitalization of $2.30 trillion. </p>
<p><strong>Buying $1000 In GOOGL:</strong> If an investor had bought $1000 of GOOGL stock 10 years ago, it would be worth <strong>$6,258.05</strong> today based on a price of $186.06 for GOOGL at the time of writing.</p>
<h3>Alphabet's Performance Over Last 10 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1720729899_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


GOOGL

$1000 Invested In Alphabet 10 Years Ago Would Be Worth This Much Today

<p>The Company is working diligently and expects to file its Form 10-Q within the next three weeks, which would eliminate the need for the Company to submit a formal plan to regain compliance.</p>


QOMO

Qomolangma Acquisition Receives Notice From Nasdaq Regarding Not Filing Quarterly Report

Insider Trades

NVDA

NVIDIA Director Mark A. Stevens Sells 785K Shares At Average Price Of $132.48

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/AUSAF"><strong>Australis Capital</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/AUSAF#OTC">AUSAF</a>) shares closed up 9900.00% at $0.0001</li>
<li><a href="https://www.benzinga.com/quote/CARA"><strong>Cara Therapeutics</strong></a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARA#NASDAQ">CARA</a>) shares closed up 25.84% at $0.37</li>
<li><a href="https://www.benzinga.com/quote/FFNTF"><strong>4Front Ventures</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FFNTF#OTC">FFNTF</a>) shares closed up 23.42% at $0.10</li>
<li><a href="https://www.benzinga.com/quote/BLOZF"><strong>Cannabix Technologies</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BLOZF#OTC">BLOZF</a>) shares closed up 15.92% at $0.43</li>
<li><a href="https://www.benzinga.com/quote/FUAPF"><strong>Global Compliance</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FUAPF#OTC">FUAPF</a>) shares closed up 12.75% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/XXII"><strong>22nd Century Group</strong></a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XXII#NASDAQ">XXII</a>) shares closed up 11.92% at $0.79</li>
<li><a href="https://www.benzinga.com/quote/CURLF"><strong>Curaleaf Holdings</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>) shares closed up 9.71% at $4.18</li>
<li><a href="https://www.benzinga.com/quote/SOLCF"><strong>SOL Glb Inv</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SOLCF#OTC">SOLCF</a>) shares closed up 9.05% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/OGI"><strong>OrganiGram Holdings</strong></a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OGI#NASDAQ">OGI</a>) shares closed up 7.59% at $1.70</li>
<li><a href="https://www.benzinga.com/quote/CNPOF"><strong>RIV Capital</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNPOF#OTC">CNPOF</a>) shares closed up 7.14% at $0.10</li>
<li><a href="https://www.benzinga.com/quote/GRWG"><strong>GrowGeneration</strong></a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRWG#NASDAQ">GRWG</a>) shares closed up 6.82% at $2.35</li>
<li><a href="https://www.benzinga.com/quote/ACB"><strong>Aurora Cannabis</strong></a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>) shares closed up 6.68% at $6.12</li>
<li><a href="https://www.benzinga.com/quote/SNDL"><strong>SNDL</strong></a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDL#NASDAQ">SNDL</a>) shares closed up 6.37% at $2.18</li>
<li><a href="https://www.benzinga.com/quote/EAST"><strong>Eastside Distilling</strong></a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EAST#NASDAQ">EAST</a>) shares closed up 6.33% at $1.19</li>
<li><a href="https://www.benzinga.com/quote/GTBIF"><strong>Green Thumb Industries</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GTBIF#OTC">GTBIF</a>) shares closed up 5.04% at $11.87</li>
<li><a href="https://www.benzinga.com/quote/CRLBF"><strong>Cresco Labs</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CRLBF#OTC">CRLBF</a>) shares closed up 5.03% at $1.67</li>
<li><a href="https://www.benzinga.com/quote/CXXIF"><strong>C21 Investments</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CXXIF#OTC">CXXIF</a>) shares closed up 4.35% at $0.25</li>
<li><a href="https://www.benzinga.com/quote/CNBX"><strong>CNBX Pharmaceuticals</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNBX#OTC">CNBX</a>) shares closed up 4.23% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/SMG"><strong>Scotts Miracle Gro</strong></a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMG#NYSE">SMG</a>) shares closed up 4.18% at $63.85</li>
<li><a href="https://www.benzinga.com/quote/ESE"><strong>ESCO Technologies</strong></a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESE#NYSE">ESE</a>) shares closed up 4.13% at $114.00</li>
<li><a href="https://www.benzinga.com/quote/BMMJ"><strong>Body and Mind</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BMMJ#OTC">BMMJ</a>) shares closed up 3.60% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/CRBP"><strong>Corbus Pharmaceuticals</strong></a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>) shares closed up 3.59% at $53.34</li>
<li><a href="https://www.benzinga.com/quote/VFF"><strong>Village Farms Intl</strong></a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>) shares closed up 3.33% at $1.00</li>
<li><a href="https://www.benzinga.com/quote/CBWTF"><strong>Auxly Cannabis Group</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBWTF#OTC">CBWTF</a>) shares closed up 3.17% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/SOL"><strong>Emeren Group</strong></a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOL#NYSE">SOL</a>) shares closed up 3.11% at $1.76</li>
<li><a href="https://www.benzinga.com/quote/CRON"><strong>Cronos Group</strong></a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRON#NASDAQ">CRON</a>) shares closed up 3.03% at $2.38</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/LMLLF"><strong>Pharmadrug</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LMLLF#OTC">LMLLF</a>) shares closed down 67.22% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/LVRLF"><strong>CordovaCann</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LVRLF#OTC">LVRLF</a>) shares closed down 55.65% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/CNGGF"><strong>Cann Gr</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNGGF#OTC">CNGGF</a>) shares closed down 35.20% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/CBDY"><strong>Target Group</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBDY#OTC">CBDY</a>) shares closed down 33.52% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/RSSFF"><strong>Affinor Growers</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RSSFF#OTC">RSSFF</a>) shares closed down 21.64% at $0.07</li>
<li><a href="https://www.benzinga.com/quote/RMHB"><strong>Rocky Mountain High</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RMHB#OTC">RMHB</a>) shares closed down 12.73% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/ITHUF"><strong>iAnthus Capital Hldgs</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ITHUF#OTC">ITHUF</a>) shares closed down 7.65% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/MRMD"><strong>MariMed</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MRMD#OTC">MRMD</a>) shares closed down 7.43% at $0.16</li>
<li><a href="https://www.benzinga.com/quote/MGWFF"><strong>Maple Leaf Green World</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MGWFF#OTC">MGWFF</a>) shares closed down 7.41% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/NWVCF"><strong>EnWave</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NWVCF#OTC">NWVCF</a>) shares closed down 5.06% at $0.17</li>
<li><a href="https://www.benzinga.com/quote/UGRO"><strong>Urban-gro</strong></a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UGRO#NASDAQ">UGRO</a>) shares closed down 3.95% at $1.46</li>
<li><a href="https://www.benzinga.com/quote/YCBD"><strong>cbdMD</strong></a> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#AMEX">YCBD</a>) shares closed down 3.23% at $0.57</li>
</ul>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


AUSAF

BLOZF

BMMJ

CARA

CBDY

CANNABIS WHEATON INCOME by Cannabis Wheaton Income Corp.

CBWTF

CNBX

CNGGF

CNPOF

CRBP

CRLBF

CRON

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

CXXIF

EAST

FFNTF

FUAPF

GRWG

GTBIF

ITHUF

LMLLF

LVRLF

MGWFF

MRMD

NWVCF

RMHB

RSSFF

SNDL

SOLCF

UGRO

XXII

YCBD

Marijuana Stock Movers For July 11, 2024

<p><strong><em>By <a href="https://elplanteo.com/author/lucia-tedesco/" target="_blank" rel="noreferrer noopener">Lucía Tedesco</a> via <a href="https://elplanteo.com/marihuana-argentina-exporta-europa/" target="_blank" rel="noreferrer noopener">El Planteo</a></em></strong></p>
<p>The Argentine, state-owned company, <strong><a href="https://elplanteo.com/cannava-cannabis-empresa-jujuy/">Cannava</a>,</strong> has successfully completed its first export of cannabis flowers to Europe and Australia. This milestone is the result of six years of research, development and production efforts to establish the province of Jujuy as a leader in the export of pharmaceutical-grade cannabis.</p>
<p>Under the direction of <strong>Gastón Morales,</strong> the Jujuy-based company has secured contracts to ship cannabis flower to Germany, Portugal and Australia. These flowers, with high THC content (ranging from 20% to 27%), are exclusively for therapeutic use. &#8220;Based on these contracts alone, we have received purchase orders for 730 kilograms of flowers for three destinations, representing an annual revenue of EUR 5 million ($5.4 million),&#8221; Morales told Infobae.</p>
<h3 class="wp-block-heading">The Economic Impact Of Argentine Marijuana</h3>
<p>The international advance in the use of medicinal cannabis is coupled with a significant economic impact on the province of Jujuy. Revenue is expected to grow to EUR 7.6 million in the second year, &#8220;with sustained demand growth of 5% annually,&#8221; Morales noted.</p>
<p>In 2023, a team from Cannava traveled to Switzerland and Germany to present its work at the Finca El Pongo. The team was &#8220;assisted by the embassy in Germany, which facilitated a series of meetings with European companies,&#8221; according to the company&#8217;s director. These commercial alliances secured long-term supply contracts for the organization.</p>
<p>This year, Cannava solidified its presence in Australia by signing a contract with <strong>Cannabas PTY,</strong> securing orders of 1,250 kilograms in the first year and 2,500 kilograms in the second. Australia&#8217;s regulatory model allows the sale of cannabis flower in authorized pharmacies. However, due to limited local production, Australia has become a key market for cannabis imports.</p>
<p>Morales announced that in November, a call for private-sector cannabis ventures will be launched, aiming to create a public-private production system that further strengthens the industry.</p>
<h3 class="wp-block-heading">Regulatory Challenges For Cannabis in Argentina</h3>
<p>Nonetheless, cannabis in Argentina is facing several regulatory challenges. Law 27.669 has not been fully implemented, the Regulatory Agency for Cannabis Research and Medicinal Derivatives (Ariccame) has been without appointments for seven months and delays in the patient registry (Reprocann) persist. If the future of cannabis in Argentina is so promising, why is it still challenging to recognize society&#8217;s right to this crucial plant for the international market?</p>
<p><em>This article is from an external unpaid contributor. It does not represent Benzinga&#8217;s reporting and has not been edited for content or accuracy.</em></p>


Govt-Owned Cannabis Company Exports Flower From Argentina To EU, Australia, Secures Purchase Orders Worth Millions

Irhythm Technologies (IRTC) has disclosed a new risk, in the Share Price & Shareholder Rights category. Irhythm Technologies' decision to engage in...

Irhythm Technologies' Capped Call Transactions: A Double-Edged Sword for Stock Stability?

Truist Financial analyst Richard Newitter assigned a Buy rating to the stock today. The company's shares closed last Friday at $102.68. Newitter co...

Truist Financial Releases a Buy Rating on Irhythm Technologies (IRTC)

Wells Fargo analyst Nathan Treybeck has maintained their bullish stance on IRTC stock, giving a Buy rating on May 6. Nathan Treybeck has given his ...

Irhythm Technologies: A Strong Buy on Solid Growth Trajectory and Innovative Developments

iRhythm stock falls as much as 8% amid Zio media report

Nathan Treybeck, an analyst from Wells Fargo, maintained the Buy rating on Irhythm Technologies (IRTC – Research Report). The associated price targ...

Irhythm Technologies: Overreaction to Media Report Presents Buy Opportunity

Citi upgrades Edwards, Tandem; cuts Nevro, Establishment Labs

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Globus Medical (GMED – Research Report), Irhythm Tec...

Analysts Are Bullish on Top Healthcare Stocks: Globus Medical (GMED), Irhythm Technologies (IRTC)

In a report released yesterday, Michael Polark from Wolfe Research upgraded Irhythm Technologies (IRTC – Research Report) to a Buy, with a price ta...

Irhythm Technologies: Poised for Profitability and Market Expansion Amidst Regulatory Advancements

iRhythm gains as Wolfe upgrades on valuation

Oppenheimer's top SMID ideas within high-growth themes

AVDL

BPMC

CCOI

ENVX

ESTA

FRPT

GCMG

GEHC

GENI

GMED

GWRE

ISRG

MDGL

MLTX

NVRO

PACS

PODD

RXST

TNDM

VECO

VKTX

ZETA

Legal

Press Releases

Investigation Alert Amylyx, Hut 8, Xponential Fitness, and iRhythm Technologies: Submit Your Information Now to Johnson Fistel, LLP

iRhythm Technologies to Report First Quarter 2024 Financial Results on May 2, 2024

NASDAQ: IRTC Lawsuit Notice: Investors who lost money with iRhythm Technologies, Inc. (NASDAQ: IRTC) shares should contact the Shareholders Foundation

Earnings

iRhythm Technologies Announces First Quarter 2024 Financial Results

Investigation Alert Hut 8, Xponential Fitness, and iRhythm Technologies: Submit Your Information Now to Johnson Fistel, LLP

IRHYTHM ALERT: Bragar Eagel & Squire, P.C. is Investigating iRhythm Technologies, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

iRhythm Technologies to Present at the William Blair 44th Annual Growth Stock Conference

iRhythm Technologies to Present at the 2024 Truist Securities MedTech Conference

iRhythm Technologies Achieves Significant Operational Milestone with Launch of Initial Phase of Manufacturing Automation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

iRhythm Technologies

News

에 대한 최신 뉴스 iRhythm Technologies (NASDAQ:IRTC) 주식

Monday, June 24, 2024

People Also Watch